Kazuomi Kario
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (33)
Hypertension remains a leading global cause of cardiovascular morbidity and mortality, yet blood pressure control rates remain suboptimal despite advances in antihypertensive therapy. Multiple barriers—including cost, side effects, therapeutic complexity, and physician inertia—impede effective management, particularly in aging populations and low-resource settings. This review evaluates the therapeutic role of doxazosin, particularly in its extended-release gastrointestinal therapeutic system formulation, as a potential adjunct in contemporary hypertension treatment, including resistant hypertension.
Year:
2026
Year:
2026
Year:
2026
Year:
2026
The second Asia Renal Denervation Consortium consensus conference shared information and developed updated recommendations for renal denervation (RDN). Current evidence confirms that RDN significantly reduces blood pressure across all metrics (office, home, and ambulatory) throughout 24 hours. Modern RDN approaches target the distal main renal artery and branches where nerves more closely approximate the vessel wall. Understanding renal artery anatomy is crucial; the main renal artery typically divides into anterior and posterior divisions as first-order branches, which further subdivide into second-order segmental arterial branches. Renal artery electrical stimulation shows promise as a procedural end point, with blood pressure response attenuation after successful RDN suggesting adequate denervation, though the optimal procedural end point remains to be established. The indication for RDN is resistant or uncontrolled hypertension, with high office, home, or 24-hour ambulatory blood pressure readings despite appropriate lifestyle modification and antihypertensive drug therapy. Preprocedure assessment includes comprehensive screening for secondary causes and detailed renal artery imaging. Checklists for preprocedure and postprocedure assessment are provided. Nocturnal hypertension and morning hypertension, which are common in Asia, are more closely associated with cardiovascular risk than daytime hypertension and are more difficult to control with current guideline-driven medication. Based on these Asian characteristics and RDN’s long-term durability, RDN should be considered an effective option for facilitating optimal 24-hour blood pressure control. Future research through real-world data collection will help determine ethnic differences in RDN response between Asians and Westerners and identify optimal candidates. In addition, studies are needed to evaluate RDN’s ability to prevent organ damage and cardiovascular events.
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Collaborators (36)
Hiroshi Itoh
Keio University School of Medicine
James Sheppard
University of Oxford
Sadayoshi Ito
Professor
Tohoku University
Karl Fengler
-
Hideo Fujita
professor
Jichi Medical University Saitama Medical Center
Felix Mahfoud
Director
University Hospital Basel
Miguel Camafort
Associate Professor
University of Barcelona
Hae-Young Lee
Seoul National University College of Medicine
Lucas Lauder
University Hospital Basel
Yoshihiro Miyamoto
Director General
National Cerebral and Cardiovascular Center
Ingrid Hopper
Monash University Malaysia.
Tomoyuki Tanigawa
St. Luke's International University
Tetsuya Matoba
Associate Professor
Kyushu University Hospital
Taishi Nakamura
Associate Professor
Kumamoto University Hospital
Wataru Umishio
Assistant Professor
Tokyo Institute of Technology
Yook-Chin Chia
Research Professor and Head of Ageing, Health and Wellbeing Research Centre (CARE)
Sunway University
Richard J. McManus
Dean
University of Oxford
Masaharu Nakayama
Professor
Tohoku University
Kenichi Tsujita
Professor of Medicine
Kumamoto University
Yoshihisa Fujino
Professor
University of Occupational and Environmental Health Japan
Satoshi Hoshide
-
Satoshi Yasuda
Professor and chairmam
Tohoku University graduate school of medicine
Stuart Pocock
Professor of Medical Statistics
London School of Hygiene & Tropical Medicine
Faisal Sharif
University of Galway
Kenichiro Otsuka
Associate Professor
Osaka University Graduate School of Medicine
Masayuki Takamura
-
keisuke narita
Jichi Medical University
Shuntaro Sato
Nagasaki University
Konstantinos Toutouzas
-
Akihiro Nomura
Assistant Professor
Kanazawa University
Atsushi Shibata
Osaka University
Daiju Fukuda
-
Asahiro Ito
Osaka University Graduate School of Medicine
Koichi Node
教授
Saga University
Keith C. Ferdinand
-
Jun Takahashi
Associate Professor
Tohoku University Hospital
Make your next move.
Prepare your application
Review drafts before you send them.